The AI in Business Podcast
Understanding AI’s Expanding Role in Drug Discovery and Life Sciences R&D - Liran Belenzon of BenchSci
Feb 26, 2025
Liran Belenzon, Co-founder and CEO of BenchSci, is a trailblazer in applying AI to drug discovery and R&D. He discusses how AI transformations are tackling the complexities of disease biology, paving the way for more efficient workflows. Liran highlights the significance of knowledge graphs and multimodal AI in enhancing research speed and quality. He emphasizes the need for flexible drug discovery processes and the importance of adapting budgets to harness AI’s full potential, balancing innovation with cost-effectiveness.
19:03
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- AI is revolutionizing drug discovery by addressing complexities in disease biology, improving decision-making and enhancing R&D workflows.
- Successful AI adoption in life sciences requires organizations to establish a clear ROI strategy to justify investments and demonstrate tangible benefits.
Deep dives
AI Transforming Drug Discovery
AI is significantly transforming drug discovery by addressing the complexities of disease biology. A major challenge in clinical trials is the misunderstanding of the biological factors influencing disease, which contributes to the failure of 90% of trials. By leveraging AI-driven insights, researchers can enhance their understanding, leading to better decision-making and accelerating the innovation process in pharmaceutical R&D. This intersection of data and technology is paving the way for a new standard in drug development.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
